Bacterium in Your Lungs May Be Attacking Your Brain

Chlamydia pneumoniae is a common respiratory bacterium responsible for millions of cases of pneumonia and sinus infections each year. Most people recover without incident, but a growing body of research suggests the bacterium doesn’t always leave. In a February 2026 study, published in Nature Communications, researchers at Cedars-Sinai found that Chlamydia pneumoniae can linger in the eye and brain for years, potentially aggravating Alzheimer’s disease. Scientists found that greater amounts of the bacterium were associated with more severe brain damage and worse cognitive decline, with elevated bacterial levels especially common in individuals carrying the APOE4 gene variant.

The mechanism is alarming. The bacterium can infect the olfactory and trigeminal nerves and reach the brain within 72 hours, while also dysregulating key pathways involved in Alzheimer’s disease pathogenesis.

The federal government has taken notice. The Senate Appropriations Committee’s FY 2026 spending bill proposed an increase of $100 million for Alzheimer’s disease and related dementias research at NIH National Institute on Aging. Researchers hope this increased funding hope will accelerate investigation into infection-driven neurodegeneration. What once seemed like an ordinary respiratory bug may prove to be one of the brain’s most dangerous long-term adversaries.

Cerebral Palsy: When a Damaged Brain Leaves a Lasting Mark

The brain injury comes first. Cerebral palsy follows. That distinction matters enormously, as CP is not itself a wound, but rather the permanent shadow one leaves behind.

The NIH’s National Institute of Neurological Disorders and Stroke guidance, reviewed as recently as March 13, 2026, describes CP as a disorder “caused by changes in the developing brain that disrupt its ability to control movement and maintain posture and balance.” The damage happens; CP is an outcome that the victim must live with in the future.

For most, the injury strikes before they ever draw a first breath. Oxygen deprivation during delivery, bleeding in the brain, or destruction of the delicate white matter surrounding a premature infant’s ventricles collectively account for roughly 80–90% of all cases. The CDC, in a February 2026 update, puts the scale in stark terms: about 1 in every 345 American children has CP, making it the most common childhood motor disability in the country.

Some cases, however, emerge after birth. Meningitis, near-drowning, and traumatic brain injury can all trigger CP, but only during the critical window when the brain is still forming, generally before age five. Once the skull has fully matured, the same injuries are referred to as traumatic brain injuries or acquired brain injuries.

To remedy what many see as the government’s chronic underfunding for CP, Tennessee Rep. Steve Cohen introduced H.R. 2178, Cerebral Palsy Research Program Authorization Act of 2025, on March 18, 2025. As he stated, “Cerebral palsy… is the most prevalent disability that has no designated federal funding for research.” After introduction, the bill was referred to the House Committee on Energy and Commerce. (No further action within the last Congressional session is reported.)

Cherry-Picking Superfoods to Aid TBI Recovery

A small red fruit that appears in various forms throughout the year is more than simply a tasty treat. Cherries pack natural pigment, known as anthocyanins, melatonin, and quercetin that cross the blood-brain barrier, reduce neuroinflammation, and protect injured neurons. It has long been known that anthocyanins cut brain injury volume by up to 27%, with anti-inflammatory potency similar to that of ibuprofen. Three more recent human randomized controlled trials also confirmed measurable improvements in memory, attention, and mental fatigue after daily tart cherry juice consumption.

These neurological improvements, highly beneficial to those with brain injuries, include a 23% reduction in memory errors in one 12-week. The NIH’s National Academies Press identified polyphenols found abundantly in cherries as interacting with neuronal survival pathways after traumatic brain injury (TBI). A 2025 review in Nutritional Neuroscience concluded that these compounds lessen neuroinflammation and oxidative stress following brain injury. An earlier comprehensive USDA-supported review of 29 human cherry studies also found cherry consumption decreased oxidative stress markers in 8 of 10 studies and reduced inflammation in 11 of 16 studies.

However, studies show that not all cherries deliver equal benefits. Montmorency tart cherries provide the highest benefits, though dark sweet varieties also carry high anthocyanin levels. Cherries also do not need to be eaten raw to be advantageous. Liquefied tart cherry juice concentrate has proven to be the most clinically validated form, though cherries that have been cooked retain significant amounts of active compounds. When frozen, cherries still provide these benefits, as they preserve 90–95% of polyphenols.

*Beyond delicious cherry pie, recipe research shows me that cherries are a feature in numerous recipes that are well-suited for every time of the day. For breakfast, for example, try cherry overnight oats (rolled oats, frozen cherries, ground flaxseed, and almond butter) which requires zero morning prep and provides steady brain energy. A cherry-chocolate brain smoothie is a good snack (tart cherries blended with cocoa powder, spinach, chia seeds, and almond milk) that delivers anthocyanins and omega-3s in one glass. For TBI-related sleep disruption, tart cherry turmeric bedtime tea (cherry juice simmered with ginger, turmeric, and chamomile) supports both natural melatonin production and neuroinflammation recovery simultaneously.

University of Alabama’s COMPASS for Brain Injury Care

The University of Alabama officially launched the COMPASS Brain Health Initiative (Comprehensive Post-Acute Specialty Services) on March 4, 2026, becoming the first clinic of its kind in Alabama. The program provides free, same-day interdisciplinary evaluations for individuals living with the persistent effects of traumatic brain injury.

COMPASS is entirely funded by the Alabama Department of Rehabilitation Services (ADRS), making every evaluation free of charge. The state’s involvement runs deep: planning began in October 2025, funding was secured in December 2025, and collaboration spans the Governor’s Office, the Alabama Department of Veterans Affairs, the Department of Mental Health, and the justice system. The clinic serves an estimated 102,000 Alabamians living with TBIs, with patients split roughly equally between civilians and veterans.

ADRS TBI Director April B. Turner underscored the program’s significance: “There’s nothing like this that exists. Having a clinic where our veterans or the guard or folks in long-term recovery can come into our centers, and… have specialists that we can refer them to for free…is just pivotal.”

(ADRS also announced five satellite TBI centers across the state, in Birmingham, Mobile, Decatur, Opelika, and Enterprise, extending COMPASS’s reach statewide.)

“Eat Your Vegetables” for a Healthy Brain

Vitamin K is generally known for its role in blood clotting, but scientists have long been uncovering its powerful impact on brain health. Available to view through PubMed, biochemical journal Biofactors noted as far back as 2012, “There is now convincing evidence that vitamin K has important actions in the nervous system.” A 2022 study published in Nature, also available on PubMed, found that vitamin K suppresses ferroptosis, a type of cell death driven by lipid damage and linked to brain injury. 

Vitamin K activates brain proteins Gas6 and protein S, which shield neurons from damage and support cell recovery after injury. While the vitamin is important for all people’s brain health, it is life-or-death for infants. The CDC has reported that babies who don’t receive a vitamin K shot at birth are 81 times more likely to develop Vitamin K Deficiency Bleeding [VKDB]. Between 30% and 60% of late-onset cases of VKDB involve brain hemorrhage, and one in five affected infants will die.

More recently, the public medical library published a 2025 Tufts University study, first reported in The Journal of Nutrition, that confirmed “low vitamin K intake reduced menaquinone-4 concentrations in brain tissues and impaired learning- and memory-related cognitive function.” 

Beyond neuroprotection, the NIH Office of Dietary Supplements notes that Vitamin K strengthens bones and supports healthy blood circulation. The old adage of “eat your vegetables” is apropos, as top food sources include kale, spinach, broccoli, and Brussels sprouts.    

Developing the “Dancing Molecule”

Northwestern University scientists have developed an injectable nanomaterial, dubbed “dancing molecules”, that cross the blood-brain barrier and shield brain tissue from post-stroke damage. Published January 2026 in Neurotherapeutics, the therapy uses tiny, constantly moving molecular assemblies, known as supramolecular therapeutic peptides (STPs), delivered intravenously that self-organize into nanofibers inside injured brain tissue. In mice, a single IV dose given after blood flow was restored significantly reduced inflammation, tissue death, and harmful immune response with no observed toxicity.

In July 2025, Amphix Bio, the company behind the treatment, posted on LinkedIn: “We are thrilled to announce the FDA has granted an Orphan Drug Designation to AMFX-200, our lead candidate based on the Supramolecular Therapeutic Peptide (STP) platform, for the treatment of acute spinal cord injury. This will accelerate our efforts to bring this novel neuro-regenerative therapeutic to the clinic.”*

* I cannot find any record of human trials of this stroke treatment, as of yet. Additionally, key limitations remain, as results are preclinical only, dosing must be precise to prevent blood clotting, and long-term human safety is unproven.

Liquid Gold for Your Brain: Extra Virgin Olive Oil

Your pantry might hold one of the most powerful brain-protective foods on the planet. Research now links extra virgin olive oil (EVOO), long recognized as a boon to heart health, to a sharply lower risk of dementia, faster brain injury recovery, and protection against the toxic plaques that drive Alzheimer’s disease.

The National Institute on Aging states, “Consuming olive oil is associated with lowering the risk of dementia-related death.” This association was found to be true “regardless of overall diet quality”. These findings were compelling enough that the 2025–2030 U.S. Dietary Guidelines, issued by USDA and HHS, placed olive oil at the center of the new federal nutrition framework.

The 2026 PREDIMED-Plus study, which focused on the benefits of the Mediterranean diet for reducing the risk of type 2 diabetes, revealed that EVOO works through the gut-brain axis, with participants showing improved memory and cognitive function alongside greater microbiota diversity. Animal studies from 2025 showed that oleocanthal, a polyphenol unique to high-quality EVOO, reduced brain infarct size and sped recovery after traumatic brain injury.

The key is EVOO’s polyphenols, specifically oleocanthal, oleuropein, and hydroxytyrosol, which cross the blood-brain barrier, clear amyloid plaques, and calm neuroinflammation. Only cold-pressed extra virgin oil retains these compounds at therapeutic levels, so quality matters. Refined olive oil could not replicate these results.

Ready to cook for your brain? Try combining EVOO with other ingredients known to promote brain health, such as salmon, or another staple of the Mediterranean diet, mint.

Pentagon’s New Coding Rules Aim to Protect Warfighters

On January 23, 2026, the Department of Defense’s Traumatic Brain Injury Center of Excellence published updated ICD-10-CM coding guidance specifically for warfighter brain injuries. ICD-10-CM (International Classification of Diseases, 10th Revision, Clinical Modification) is the standardized system doctors use to classify and record diagnoses. Without precise codes, injuries go miscounted and undertreated.

The new guidance is particularly critical now, as modern warfare inflicts unique brain hazards. Low-level blast overpressure from repeated weapons firing, extreme G-forces on pilots, and unexplained neurological incidents now have dedicated diagnostic codes, enabling better surveillance and resource allocation.

Just days earlier, on January 20, the Center released a research review revealing that mild TBI raises PTSD risk two- to threefold, findings that will shape military treatment protocols. Meanwhile, the Army’s baseline cognitive screening program, launched in August 2024, aims to assess every troop’s brain health proactively.

Studies Explore Plasma as Key to Human Survival & Recovery

Fresh frozen plasma, the liquid part of blood stripped of red and white cells, may hold the key to saving more lives after traumatic brain injury. The U.S. Department of Defense has been funding research on this for over a decade. While significant studies remain in operation and, therefore, a comprehensive review cannot yet be reported, the results are increasingly hard to ignore.

The most significant step forward is the FIT-BRAIN Trial, a federally funded study that began enrolling patients in early 2024 across eight U.S. trauma centers. Researchers at Northwestern University, backed by the Pentagon’s Congressionally Directed Medical Research Program, are testing whether plasma given soon after a severe brain injury can limit damage and improve survival. (The trial targets 357 patients, with results expected around 2027.)

Other recent studies have already built the case. A January 22, 2025 paper in the Annals of Surgery journal, driven by federally-funded studies, found that patients given cold-stored platelets after brain injury needed emergency skull surgery 14 percent less often and a 2025 analysis of nearly 15,000 children with severe brain injuries found that plasma given within four hours cut early death risk by nearly half.

In Fiscal Year 2025, Congressionally Directed Medical Research Programs funding was cut 57%, to $650 million, with Traumatic Brain Injury and Psychological Health Research Programs receiving zero dollars for new research grants. Recently, FY2025’s financial research crisis was partially resolved. On February 3, 2026, President Trump signed the Consolidated Appropriations Act, 2026 (P.L. 119-75), restoring CDMRP funding to $1.27 billion across 34 research programs.

A Gift from the Heart to the Mind

This Valentine’s Day, that box of dark chocolates may offer more than romance. A body of research indexed in PubMed reveals that dark chocolate’s primary flavanol, epicatechin, is a potent neuroprotective compound with remarkable potential for brain injury recovery.

“Epicatechin represents a promising therapeutic candidate for traumatic brain injury – its multi-pathway neuroprotection, from antioxidant defense to neurogenesis, makes it unlike any single pharmaceutical agent,” stated Wang et al. in 2024 in CNS Neuroscience & Therapeutics. Research shows that administering epicatechin after traumatic brain injury prevents neuronal death, reduced neuroinflammation, and restored neurological function by targeting the AKT-P53/CREB signaling pathway. This pathway then promotes cell growth and inhibits apoptosis. A 2025 meta-analysis in the Journal of Agricultural and Food Chemistry pooled 12 animal studies and confirmed epicatechin significantly improves outcomes across TBI, ischemic stroke, and other brain injury types, while reducing oxidative stress and boosting antioxidant defenses.

Dark chocolate’s brain benefits operate through multiple pathways: boosting cerebral blood flow by 8-10% via nitric oxide–mediated vasodilation, activating the Nrf2 antioxidant system, elevating the brain-derived neurotrophic factor critical for neuronal survival, and stimulating neurogenesis. Crucially, these are the very mechanisms disrupted by traumatic brain injury and stroke.

While most current TBI-specific evidence remains in animal models, the results are compelling. This Valentine’s Day, choose dark chocolate with the highest cocoa content you can find, preferably 70% or above. Your brain, and your loved one’s brain, will thank you.